Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3p

5 Nov 2020

Abstract excerpt

BACKGROUND: Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA (lncRNA) that regulates disease progression in various types of cancers. The aim of this study was to explore the role of MALAT1 in breast cancer (BC) progression and doxorubicin resistance. METHODS: Real-time polymerase chain reaction (RT-PCR) was used to determine the expression of MALAT1 in BC tissues and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cancer-related molecular mechanisms research
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35410813
DOI: 10.1016/j.bj.2020.11.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3pPMID 35410813Read ↗

The MALAT1-breast cancer interplay: insights and implicationsSemantic proximity Read ↗

Long non-coding RNA MALAT1 in hematological malignancies and its clinical applicationsSemantic proximity Read ↗

MALAT1: a potential biomarker in cancerSemantic proximity Read ↗

Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.Semantic proximity Read ↗

Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysisSemantic proximity Read ↗

Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.Semantic proximity Read ↗

Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.Semantic proximity Read ↗

Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistanceSemantic proximity Read ↗

Long Non‐Coding RNA MALAT1 Interacts With miR‐204 to Modulate Human Hilar Cholangiocarcinoma Proliferation, Migration, and Invasion by Targeting CXCR4Semantic proximity Read ↗

LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancerSemantic proximity Read ↗

MALAT1-related signaling pathways in colorectal cancerSemantic proximity Read ↗

MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.